Buchumschlag

Can we prevent fatal liver failure under valproate?

Valproic acid (VPA) has been used as an anticonvulsant for more than 30 years. Meanwhile, VPA has also been approved by the FDA for the treatment of bipolar disorders. We report the case of a 58-year-old female patient, who died from liver failure, probably due to treatment with VPA.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schmid, Markus (VerfasserIn) , Connemann, B. J. (VerfasserIn) , Wolf, R. C. (VerfasserIn) , Flechtenmacher, Christa (VerfasserIn) , Eisenbach, Christoph (VerfasserIn) , Schönfeldt-Lecuona, C. (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 25. Mai 2010
In: Pharmacopsychiatry
Year: 2010, Jahrgang: 43, Heft: 5, Pages: 198-200
ISSN:1439-0795
DOI:10.1055/s-0030-1254125
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0030-1254125
Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0030-1254125
Volltext
Verfasserangaben:M.M. Schmid, B.J. Connemann, R.C. Wolf, C. Flechtenmacher, C. Eisenbach, C. Schönfeldt-Lecuona
Beschreibung
Zusammenfassung:Valproic acid (VPA) has been used as an anticonvulsant for more than 30 years. Meanwhile, VPA has also been approved by the FDA for the treatment of bipolar disorders. We report the case of a 58-year-old female patient, who died from liver failure, probably due to treatment with VPA.
Beschreibung:Gesehen am 13.06.2023
Beschreibung:Online Resource
ISSN:1439-0795
DOI:10.1055/s-0030-1254125

Ähnliche Einträge